November 10, 2010 08:00 ET

CDEX Launches New Pocket ID2 Device and Receives First Purchase Order From Lifeloc Technologies

TUCSON, AZ--(Marketwire - November 10, 2010) -  CDEX Inc. (OTCBB: CEXI) (, a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced today the launch of its new Pocket ID2 Scanner. CDEX also signed a distribution agreement with Lifeloc Technologies, a leading supplier of breath alcohol testers to law enforcement agencies, for sale of the Pocket ID2. We expect the first production of the Pocket ID2 to begin in December 2010. 

The Pocket ID2 Scanner detects trace amounts of illegal drugs, such as Methamphetamine (Meth). Studies by the National Survey on Drug Use and Health (NSDUH) have estimated Crystal Meth addiction is now the largest illegal drug pandemic gripping the nation. Another report written by the RAND Corporation in 2005 titled 'The Economic Cost of Methamphetamine Use in the United Statesestimated the cost of meth abuse at $23.4 billion annually in the US, imposing serious costs to the criminal justice system. The results of a survey conducted in 2007 by the National Association of Counties (NACO) reported by law enforcement officials from 45 states showed that Meth is still the number one drug problem agencies deal with. 

The Pocket ID2 Scanner was designed to help enforcement agencies combat this issue. The Pocket ID2 allows law enforcement officers and other agencies to carry and conceal the device easily. The Pocket ID2 was developed with the Company's patented technologies that detect and verify the presence of meth down to trace quantities in the low nanogram range. Test results are instantaneous and non-destructive and can be conducted without touching or disturbing the surfaces scanned, thus minimizing officer exposure and preserving the integrity of the sample. The innovative technology is designed for use in law enforcement, correctional facilities and other applications where definitive and immediate results are necessary. 

Lifeloc Technologies is a leading supplier of breath alcohol testers for domestic and international law enforcement, corrections, and workplace testing.

"We're pleased to be working with CDEX in the commercialization and market development of this enormously important detection technology," said Barry Knott, President of Lifeloc Technologies. "The Pocket ID2 Scanner is a significant step forward in equipping law enforcement with the tools they need to win the war on drugs."

Jeff Brumfield, CEO and Chairman of the Board of CDEX Inc., commented, "We are very pleased to launch our new Pocket ID2 Scanner and receive our first sales order from a well respected firm such as Lifeloc Technologies. We developed the Pocket ID2 after feedback from agencies in the field expressed the need for a smaller more convenient device to carry and conceal. Our research and development team successfully delivered a prototype that is small enough to carry in your pocket, which will benefit law enforcement agencies in their assault on drug crime. The field testing of the Pocket ID2 was a tremendous success and accelerated our production time line. We believe Lifeloc is a great distribution partner and brings immediate access to agencies across the U.S. and internationally. CDEX's intellectual property and proprietary processes provide many future growth opportunities in other markets where our detection applications can be deployed."

About Lifeloc Technologies
For more than 25 years Lifeloc Technologies, Inc. has served the law enforcement, corrections and workplace communities as a leading global designer and manufacturer of professional breath alcohol testers. More than 35 countries currently utilize Lifeloc's breath alcohol testing equipment for workplace, DOT, law enforcement, education and corrections testing. Lifeloc products, proudly manufactured and serviced in the USA, are recognized worldwide for their ease-of-use, accuracy and reliability. To learn more about Lifeloc and the Pocket ID2 Scanner please visit

About CDEX
CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed product line provides life-saving validation of high-risk medications and returned narcotics. The ID2™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets in the future where its proprietary products can be launched. To learn more about CDEX please visit

Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "believes," "should," "intends," and similar words. These statements pose risks that cannot be accurately predicted. Consequently, results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.

Contact Information